Preimplantation Genetic Testing Market Expansion Plans Focused at Regional Reven
Posted by Arslan on January 23rd, 2019
The preimplantation genetic testing market is likely to witness steady growth over the course of the forecast period. Preimplantation genetic testing is the procedure of testing embryos to identify genetic diseases or defects before implantation. Along with implantation of healthy embryo which results in the genetically healthy baby, the preimplantation genetic testing is done to eliminate the risk of structural chromosome abnormalities, Mendelian disorders, etc.
According to the latest report by Fact.MR, the preimplantation genetic testing market is expected to experience strong growth. The preimplantation genetic testing market is estimated to reach US$ 575.0 million revenue by 2022 end. Due to the increasing awareness of preimplantation genetic testing to avoid genetic disorders, the rise in a number of healthcare providers and healthcare institutes providing preimplantation genetic testing are the influencing factors contributing to growth of preimplantation genetic testing market.
Specialized Clinics to Account for Maximum Share
Among all other end users of preimplantation genetic testing, specialized clinics are expected to experience strong growth. Specialized clinics are estimated to exceed US$ 200 million revenue towards 2022 end. Meanwhile, hospitals are also expected to witness impressive growth in preimplantation genetic testing market.
Preimplantation Genetic Testing to find Largest Application in Embryo HLA Typing for Stem Cell Therapy
Embryo HLA typing for stem cell therapy is expected to show healthy growth from throughout 2017-2022. Embryo HLA typing for stem cell therapy is estimated to create an incremental opportunity exceeding US$ 70 million during 2017-2022.
Browse Full Report on Preimplantation Genetic Testing Market with TOC-
The report commences with a brief information of the global spine devices market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global spine devices market.
North America is likely to emerge as the biggest market in the global preimplantation genetic testing. North America preimplantation genetic testing market is projected to surpass US$ 200 million by the end of 2022. Increasing adoption of innovative technologies and rising awareness about preimplantation genetic testing to avoid various birth defects among babies are some of the factors fueling the market growth in the region.
Europe is expected to be the second most lucrative market for preimplantation genetic testing. Owing to the presence of various healthcare institutions and hospitals providing preimplantation genetic testing and high awareness due to the various initiatives by the government is driving the growth of preimplantation genetic testing in Europe.
Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research. We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include, Primary research Secondary research Trade research Focused interviews Social media analysis
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Like it? Share it!
About the AuthorArslan
Joined: December 18th, 2017
Articles Posted: 13,297
More by this author